Mannkind reported $2.5M in Ordinary Share Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acceleron Pharma XLRN:US $ 0.06M 0M
Adamas Pharmaceuticals ADMS:US 50K 0
Adma Biologics ADMA:US $ 0.01M 0M
Biodelivery Sciences International BDSI:US $ 0.1M 0M
Chemocentryx CCXI:US $ 0.07M 0M
Dicerna Pharmaceuticals DRNA:US $ 0.01M 0M
Dynavax Technologies DVAX:US $ 0.12M 0.01M
Eli Lilly And LLY:US $ 598.2M 0.1M
Flexion Therapeutics FLXN:US $ 50K 0
Halozyme Therapeutics HALO:US $ 0.14M 0M
Insmed INSM:US $ 1.18M 32K
Karyopharm Therapeutics KPTI:US $ 8K 0
Kindred Biosciences KIN:US $ 0M 0M
Macrogenics MGNX:US $ 0.61M 0.01M
Mannkind MNKD:US $ 2.5M 0.01M
Minerva Neurosciences NERV:US $ 0M 0M
Novavax NVAX:US $ 0.76M 0.01M
Novo Nordisk A Fs NVO:US $ 462M 0M
Peregrine Pharmaceuticals PPHM:US $ 0.06M 0M
Xencor XNCR:US $ 0.58M 0M